Search Results - "De Vocht, Joke"

Refine Results
  1. 1

    Suicidality among healthcare professionals during the first COVID19 wave by Bruffaerts, Ronny, Voorspoels, Wouter, Jansen, Leontien, Kessler, Ronald C., Mortier, Philippe, Vilagut, Gemma, De Vocht, Joke, Alonso, Jordi

    Published in Journal of affective disorders (15-03-2021)
    “…•We investigate suicidal thoughts and behaviors (STB) among healthcare professionals in the first COVID19 wave in belgium.•30-day STB is estimated at 4%,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Specialized multidisciplinary care improves ALS survival in Belgium: a population-based retrospective study by Hobin, Frederik, De Vocht, Joke, Lamaire, Nikita, Beyens, Hilde, Ombelet, Fouke, Van Damme, Philip

    “…ALS is a neurodegenerative disease characterized by loss of motor neurons, resulting in progressive weakness and wasting of muscles. The average survival time…”
    Get full text
    Journal Article
  4. 4

    Positive screens for mental disorders among healthcare professionals during the first covid19 wave in Belgium by Voorspoels, Wouter, Jansen, Leontien, Mortier, Philippe, Vilagut, Gemma, Vocht, Joke de, Kessler, Ronald C., Alonso, Jordi, Bruffaerts, Ronny

    Published in Journal of psychiatric research (01-08-2021)
    “…We examined the manifestation of major depressive disorder, generalized anxiety disorder, substance use disorder, post-traumatic stress disorder, and panic…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Differences in Cerebral Glucose Metabolism in ALS Patients with and without C9orf72 and SOD1 Mutations by De Vocht, Joke, Van Weehaeghe, Donatienne, Ombelet, Fouke, Masrori, Pegah, Lamaire, Nikita, Devrome, Martijn, Van Esch, Hilde, Moisse, Mathieu, Koole, Michel, Dupont, Patrick, Van Laere, Koen, Van Damme, Philip

    Published in Cells (Basel, Switzerland) (18-03-2023)
    “…Amyotrophic lateral sclerosis (ALS) is characterized by progressive loss of upper and lower motor neurons. In 10% of patients, the disorder runs in the family…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes by Devrome, Martijn, Van Weehaeghe, Donatienne, De Vocht, Joke, Van Damme, Philip, Van Laere, Koen, Koole, Michel

    Published in EJNMMI research (13-12-2018)
    “…Background 18 F-FDG brain PET measures metabolic changes in neurodegenerative disorders and may discriminate between different diseases even at an early stage…”
    Get full text
    Journal Article
  10. 10

    Prognostic value of motor and extramotor involvement in ALS by Kabir, Vincent, Ombelet, Fouke, Hobin, Frederik, Lamaire, Nikita, De Vocht, Joke, Van Damme, Philip

    “…Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder resulting in upper and lower motor neuron loss. ALS often has a focal onset of weakness,…”
    Get full text
    Journal Article
  11. 11

    TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study by Van Weehaeghe, Donatienne, Van Schoor, Evelien, De Vocht, Joke, Koole, Michel, Attili, Bala, Celen, Sofie, Declercq, Lieven, Thal, Dietmar R, Van Damme, Philip, Bormans, Guy, Van Laere, Koen

    Published in Journal of Nuclear Medicine (01-04-2020)
    “…Neuroinflammation is important in amyotrophic lateral sclerosis (ALS). The P2X7 receptor (P2X7R) is a promising target for neuroinflammation. The objective of…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics by Van Weehaeghe, Donatienne, Devrome, Martijn, Schramm, Georg, De Vocht, Joke, Deckers, Wies, Baete, Kristof, Van Damme, Philip, Koole, Michel, Van Laere, Koen

    “…Purpose Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder with on average a 1-year delay between symptom onset and diagnosis…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Is there a glucose metabolic signature of spreading TDP-43 pathology in amyotrophic lateral sclerosis? by van Weehaeghe, Donatienne, Ceccarini, Jenny, Willekens, Stefanie M, de Vocht, Joke, van Damme, Philip, van Laere, Koen

    “…Recently, four neuropathological stages of amyotrophic lateral sclerosis (ALS) with spreading of transactive response DNA-binding protein-43 pathology were…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20